Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Fatal interstitial lung disease associated with Crizotinib pathologically confirmed by percutaneous lung biopsy in a patient with ROS1-rearranged advanced non-small-cell lung cancer: a case report

Fig. 3

Somatic mutation matrix of genes screened using a circulating single-molecule amplification and resequencing technology (cSMART) panel. Each solid bar in the matrix represents a somatic mutation of a gene (row) in the tested sample (column), with colour codes including light grey for no somatic mutation and red for the presence of a somatic mutation, as indicated. Alternative allele fractions of somatic mutations are labelled with a different colour depth, as indicated by the colour key at the bottom of the figure. Z17L06517: pretreatment NGS. Z17L03579: post-treatment NGS

Back to article page